• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合手术和抗真菌治疗在血液恶性肿瘤患者侵袭性曲霉菌病治疗中的疗效。

Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.

出版信息

Mycoses. 2010 Jan;53(1):89-92. doi: 10.1111/j.1439-0507.2008.01672.x. Epub 2009 Feb 3.

DOI:10.1111/j.1439-0507.2008.01672.x
PMID:19207832
Abstract

We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with haematological malignancies that were successfully treated with liposomal amphotericin B and surgical debridement, followed by oral administration of posaconazole. These cases demonstrated that an early instituted, aggressive and combined therapeutic approach results in a recovery from invasive fungal infection, without any relapse of infection, thanks to secondary prophylaxis using posaconazole.

摘要

我们报告了两例侵袭性曲霉菌病发生在严重免疫功能低下的血液病恶性肿瘤患者,他们成功地接受了脂质体两性霉素 B 和手术清创治疗,随后口服泊沙康唑。这些病例表明,早期采用积极的联合治疗方法可使患者从侵袭性真菌感染中康复,由于使用泊沙康唑进行二级预防,没有任何感染复发。

相似文献

1
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.联合手术和抗真菌治疗在血液恶性肿瘤患者侵袭性曲霉菌病治疗中的疗效。
Mycoses. 2010 Jan;53(1):89-92. doi: 10.1111/j.1439-0507.2008.01672.x. Epub 2009 Feb 3.
2
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.一名心脏移植患者在伏立康唑治疗曲霉病期间发生接合菌病重叠感染,采用脂质体两性霉素和泊沙康唑成功治愈。
Transpl Infect Dis. 2012 Oct;14(5):E56-9. doi: 10.1111/j.1399-3062.2012.00772.x. Epub 2012 Jul 31.
3
ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies.颧骨骨髓炎:血液恶性肿瘤患者的当前治疗方法。
Br J Haematol. 2009 Sep;146(6):597-606. doi: 10.1111/j.1365-2141.2009.07738.x. Epub 2009 May 18.
4
Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole.两名移植受者接受脂质体两性霉素B和部分手术切除治疗,随后使用泊沙康唑,成功治愈肺接合菌病。
Mycoses. 2010 Mar 1;53(2):163-7. doi: 10.1111/j.1439-0507.2008.01666.x. Epub 2009 Jan 9.
5
[Invasive zygomycosis in patients treated for haematological malignancies].[血液系统恶性肿瘤患者的侵袭性接合菌病]
Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2597-602.
6
Current experience in treating invasive zygomycosis with posaconazole.泊沙康唑治疗侵袭性毛霉病的当前经验。
Clin Microbiol Infect. 2009 Oct;15 Suppl 5:77-81. doi: 10.1111/j.1469-0691.2009.02985.x.
7
Cutaneous zygomycosis.皮肤接合菌病。
Clin Dermatol. 2012 Jul-Aug;30(4):413-9. doi: 10.1016/j.clindermatol.2011.09.013.
8
Forty-one recent cases of invasive zygomycosis from a global clinical registry.全球临床注册中心的 41 例侵袭性接合菌病近期病例。
J Antimicrob Chemother. 2010 Feb;65(2):296-302. doi: 10.1093/jac/dkp430. Epub 2009 Dec 11.
9
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.延迟基于两性霉素B的一线治疗会显著增加患有接合菌病的血液系统恶性肿瘤患者的死亡率。
Clin Infect Dis. 2008 Aug 15;47(4):503-9. doi: 10.1086/590004.
10
[Mucormycosis: therapeutic news].[毛霉病:治疗进展]
Med Sci (Paris). 2013 Mar;29 Spec No 1:25-30. doi: 10.1051/medsci/201329s106. Epub 2013 Mar 13.

引用本文的文献

1
Severe dual fungal infection after bispecific antibody therapy: A case of invasive aspergillosis and mucormycosis in immunocompromised patient.双特异性抗体治疗后发生严重双重真菌感染:1例免疫功能低下患者的侵袭性曲霉病和毛霉病
IDCases. 2024 Dec 22;39:e02140. doi: 10.1016/j.idcr.2024.e02140. eCollection 2025.
2
Post-COVID Mucormycosis-Conceptual Etiology and New Treatment Options.新冠后毛霉菌病——概念性病因及新的治疗选择
J Maxillofac Oral Surg. 2024 Dec;23(6):1516-1527. doi: 10.1007/s12663-024-02124-5. Epub 2024 May 16.
3
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.
全球毛霉病诊断和管理指南:欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
4
Invasive coinfection with Aspergillus and Mucor in a patient with acute myeloid leukemia.急性髓系白血病患者侵袭性曲霉和毛霉合并感染。
Clin Drug Investig. 2013 Feb;33 Suppl 1:S51-5. doi: 10.1007/s40261-012-0022-4.
5
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.由非根霉属、毛霉属和亮菌属的异常毛霉引起的毛霉病。
Clin Microbiol Rev. 2011 Apr;24(2):411-45. doi: 10.1128/CMR.00056-10.